Health & Medicine
-
TechPlans fizzled for nuclear-powered artificial heart
In 1965, researchers saw a nuclear-powered heart in the future.
By Beth Mole -
Health & MedicineProspective Crohn’s drug yields high rate of remission
An experimental Crohn’s disease drug triggers a high remission rate in patients.
By Nathan Seppa -
Health & MedicineFor heart repair, call RNA
Mice regrow muscle cells after heart attacks if injected with molecules mimicking RNA involved in cell growth.
-
Health & MedicineAspirin, other painkillers may not reduce colorectal cancer risk for everybody
Aspirin and NSAIDs appear widely protective against colorectal cancer, but not for everyone.
By Nathan Seppa -
Health & MedicineIn babies, turning down inflammation soothes the hurt
Babies don’t feel nerve pain because their immune systems tamp down inflammation.
-
Health & MedicineRise in measles cases predicted in Ebola-stricken areas
Disruptions in vaccination campaigns in West Africa during the Ebola outbreak could lead to as many as 16,000 deaths from measles in the coming months.
By Nathan Seppa -
LifeFor healthy eating, timing matters
Limiting eating times improves heart function in fruit flies.
-
LifeChickens to blame for spread of latest deadly bird flu
Chickens are responsible for the second wave of H7N9 bird flu in China.
-
Health & MedicineTeens have higher anaphylaxis risk than younger kids
Adolescents may be more apt to experience an extreme allergic reaction than younger children, researchers report.
By Nathan Seppa -
LifeExperimental herpes vaccine works in mice
An experimental herpes vaccine works in animal tests by using an approach starkly different from that used in previous vaccine development.
By Nathan Seppa -
Health & MedicineArsenic spurs adaptation in Argentinian villagers
The people of San Antonio de los Cobres, Argentina, have genetic adaptations that may help them efficiently get rid of arsenic, a new study shows.
-
Health & MedicineHepatitis E vaccine shows strong coverage
A large trial in China indicates that a vaccine can provide 87 percent protection against the hepatitis E virus, which infects 20 million people a year.
By Nathan Seppa